NASDAQ: OTLK Outlook Therapeutics, Inc. 8-K

Outlook Therapeutics raises capital via 8.5M share registered direct offering to single investor

Filed May 29, 2026 · Period ending May 29, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade OTLK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 29, 2026 10:10 PM